CDK4 and breast cancer: CDK4/6i resistant BC cells evade the control of ER signaling through PI3K/Akt/mTOR signaling pathway and CDK4/6i activates the PI3K/Akt pathway by PDK1 phosphorylation of Akt at S477/T479.